Pavol Tomašov

Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry

Josef Veselka, Morten K. Jensen, Max Liebregts et al. · European Heart Journal · 2016 · 197 citations · Full text

Long-Term Effects of Varying Alcohol Dosing in Percutaneous Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: A Randomized Study With a Follow-up up to 11 Years

Josef Veselka, Pavol Tomašov, David Zemánek · Canadian Journal of Cardiology · 2011 · 49 citations

Cardiomyopathy, Cardiovascular Disease, Randomized Study +7

Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: ultra-low dose of alcohol (1 ml) is still effective

Josef Veselka, David Zemánek, Pavol Tomašov et al. · Heart and Vessels · 2009 · 46 citations

Alcohol Septal Ablation, Heart Failure, Cardiomyopathy +6

Mutations in NEBL encoding the cardiac Z-disk protein nebulette are associated with various cardiomyopathies

Andreas Perrot, Pavol Tomašov, Eric Villard et al. · Archives of Medical Science · 2016 · 36 citations · Full text

Obstruction after alcohol septal ablation is associated with cardiovascular mortality events

Josef Veselka, Pavol Tomašov, Jaroslav Januška et al. · Heart · 2016 · 36 citations · Full text